Haemonetics Corp (HAE)
24.82 x 1 N/A x N/A
Post-market by (Cboe BZX)
62.51 +0.59 (+0.95%) 04/25/25 [NYSE]
24.82 x 1 N/A x N/A
Post-market 62.51 unch (unch) 16:01 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 117,558 | 115,401 | 43,375 | 79,469 | 76,526 |
Depreciation Amortization | 103,737 | 95,277 | 101,151 | 84,851 | 110,885 |
Income taxes - deferred | -11,039 | 4,783 | 5,013 | -19,866 | -6,958 |
Accounts receivable | -24,193 | -24,421 | -34,974 | 44,121 | 18,863 |
Other Working Capital | -74,701 | 25,503 | -15,177 | -59,682 | -84,562 |
Other Operating Activity | 70,389 | 56,515 | 72,875 | -20,088 | 43,463 |
Operating Cash Flow | $181,751 | $273,058 | $172,263 | $108,805 | $158,217 |
Cash Flows From Investing Activities | |||||
PPE Investments | -64,486 | -108,583 | -94,487 | -35,225 | -31,984 |
Net Acquisitions | -242,352 | -2,000 | 8,142 | -390,217 | -25,192 |
Other Investing Activity | -15,551 | -33,205 | 0 | 0 | 0 |
Investing Cash Flow | $-322,389 | $-143,788 | $-86,345 | $-425,442 | $-57,176 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | N/A | -60,000 | 45,000 |
Debt Issued | 110,000 | 330,000 | 0 | 500,000 | N/A |
Debt Repayment | -72,250 | -339,625 | -17,500 | -21,875 | -13,125 |
Common Stock Issued | 7,214 | 7,016 | 6,547 | -37,170 | 12,016 |
Common Stock Repurchased | N/A | -75,000 | N/A | N/A | -175,000 |
Other Financing Activity | -6,807 | -22,755 | -4,796 | -13,503 | -99 |
Financing Cash Flow | $38,157 | $-100,364 | $-15,749 | $367,452 | $-131,208 |
Exchange Rate Effect | -3,185 | -3,936 | -2,978 | 4,179 | -1,873 |
Beginning Cash Position | 284,466 | 259,496 | 192,305 | 137,311 | 169,351 |
End Cash Position | 178,800 | 284,466 | 259,496 | 192,305 | 137,311 |
Net Cash Flow | $-105,666 | $24,970 | $67,191 | $54,994 | $-32,040 |
Free Cash Flow | |||||
Operating Cash Flow | 181,751 | 273,058 | 172,263 | 108,805 | 158,217 |
Capital Expenditure | -66,296 | -110,191 | -96,509 | -37,040 | -48,758 |
Free Cash Flow | 115,455 | 162,867 | 75,754 | 71,765 | 109,459 |